price month
 close
competit posit
takeaway ortho summit refin est
ortho summit manag meet takeaway met full
manag team ortho summit la vega
comprehens innov platform clear align broader
digit evolut across dentistri drive potenti demis tradit
analog bracket wire inevit question surround
competit posit new player wing grow presenc
smile direct club sdc peopl serv accord websit
well less favor price dynam disclos sdc spend
million advertis annual vs million effort
potenti posit halo effect consist view
room one player clear align market acknowledg
misstep recent promot activ also point opportun
convent price discount
programseffort encourag could take time implement
doctor beyond
examin price volum outlookreduc estim
report note asp pressur larg driven unintend respons
new promot initi bp top-line growth though
sinc discontinu asp pressur persist increment
headwind mix fx flow bottom line
comprehens case still repres overal mix view
captur greater share expand non-comprehens volum
typic involv gp level treatmenttarget massiv case
start market potenti patient current seek orthodont
treatment mix shift inevit drive consolid asp
higher captur volum theoret provid off-set light
revis price volum outlook lower ep
tp risk includ competit
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
manufactur system clear align
therapi intra-or scanner cad/cam digit servic use
dentistri orthodont dental record storag
price rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
us launch todayinnov bear fruit term innov today
launch mandibular advanc offer us follow fda
clearanc octob contribut immateri nt offer expand
algn address market vs total case start moreov
expect expand address market launch rapid
palat expand estimate view algn on-going innov continu
distanc competitor deemphas impact recent compet
product launch analysi enclos note summit quantifi
overal address market size case start vs previous disclos
includ increment opportun latin america previous includ
relev factoid summit term compet sale effort focu
diversifi competitor may limit without support broader
sale effort sale rep vs ormco/dhr defend effort
new retail concept pro-practition oppos conflict interest
seen patient date also two store open past
week total also emphas opportun area brazil
aesthetically-focus patient popul repres opportun case
start doctor train quarterli momentum itero remain key
differenti less di/cad/cam penetr
emphas broader technolog invisalign offer continu reson well
dso alik
valuat thought algn share plummet vs follow
report introduc disappoint guidanc anem asp
guidanc vs prior estimate also announc departur algn svp
america region current ceo assum relev respons
manag attribut chang natur evolut grow busi
well chief market offic raph pascaud coincid releas
recent asp commentari inevit rais concern competit
landscap view recent pullback somewhat overblown
trade ebitda vs histor average maintain
outperform highlight significantli under-penetrated market
maintain domin share market view room sever
player also support continu innov histor strong execut
new risk disclosur quarterli file identifi retail leas exposur
